BU-NOT-SET

CONTACT US
The QbD approach: Key advantages in clinical and commercial phases
  • Analytical chemistry
Lab
Insight
Sustainability report 2020
  • Sustainability
Report
Report
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
  • Drug substance
Man at poster
Poster
Recipharm Analytical Solutions™
  • Analytical chemistry
Icon
Fact sheet
Impurity identification
  • Analytical chemistry
Woman inserting vials in machine
Fact sheet
Stability studies
  • Analytical chemistry
hand holding vials plate
Fact sheet
Extractables & leachables testing
  • Analytical chemistry
Product mix
Fact sheet
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
  • Industry trends
Eyes
Insight
Global expansion in the CDMO field
  • Industry trends
Eyes
Insight
Webinar
  • Drug product
  • Manufacturing
Blow-fill-seal transforming distribution of biologics and vaccines
Insight
  • Drug product
  • Industry trends
Key factors and trends driving innovation in drug dosage forms
Insight
  • Sustainability
Water matters: How cutting back reduced Pianezza’s greenhouse gas emissions
Insight
  • Biologics
The evolving mRNA landscape
Insight
  • Sustainability
How can the pharmaceutical industry reduce its carbon footprint?
Insight
  • Biologics
Regulatory challenges in gene therapy manufacturing
Webinar
  • Drug product
Reformulation strategies to enhance and extend your drug product success
Insight
  • Biologics
Gene therapy manufacturing journey
Insight
  • Biologics
Pushing boundaries in mRNA vaccine manufacturing